🇺🇸 Hepsera in United States

2,056 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypophosphataemia — 314 reports (15.27%)
  2. Osteomalacia — 290 reports (14.11%)
  3. Fanconi Syndrome Acquired — 283 reports (13.76%)
  4. Drug Resistance — 229 reports (11.14%)
  5. Renal Impairment — 218 reports (10.6%)
  6. Arthralgia — 152 reports (7.39%)
  7. Drug Ineffective — 148 reports (7.2%)
  8. Blood Creatinine Increased — 147 reports (7.15%)
  9. Blood Phosphorus Decreased — 138 reports (6.71%)
  10. Blood Alkaline Phosphatase Increased — 137 reports (6.66%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Hepsera approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hepsera in United States?

Gilead Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.